Martínez E, Leguizamón M, Mallolas J, Miró J M, Gatell J M
Institut d'Investigacions Biomèdiques, August Pi i Sunyer, Hospital Clinic, Barcelona, Spain.
Clin Infect Dis. 1999 Aug;29(2):422-5. doi: 10.1086/520226.
We analyzed the influence of temperature, humidity, and atmospheric pressure on the 1-year incidence of nephrolithiasis among human immunodeficiency virus type 1-infected patients treated with indinavir. One hundred three patients (13.6%) developed 326 episodes of nephrolithiasis. Eighty-two patients (79.6%) had more than one episode (range, two to seven episodes). The overall incidence ranged from 0 to 10.2 episodes per 100 patients exposed per month. There was a significant correlation between temperature and the overall incidence of nephrolithiasis and the incidence of recurrences but not with the incidence of first episodes. Nephrolithiasis was not related to humidity or atmospheric pressure. Our data support the standard recommendation of drinking at least 1.5 L of water daily to prevent nephrolithiasis in most patients treated with indinavir irrespective of meteorologic factors. However, the risk of nephrolithiasis is higher for a certain subgroup of patients when the environment is hot irrespective of adequate water intake.
我们分析了温度、湿度和大气压对接受茚地那韦治疗的1型人类免疫缺陷病毒感染患者肾结石1年发病率的影响。103名患者(13.6%)出现了326次肾结石发作。82名患者(79.6%)发作次数超过一次(范围为2至7次)。总体发病率为每月每100名暴露患者0至10.2次发作。温度与肾结石总体发病率及复发率之间存在显著相关性,但与首次发作率无关。肾结石与湿度或大气压无关。我们的数据支持标准建议,即无论气象因素如何,大多数接受茚地那韦治疗的患者每天至少饮用1.5升水以预防肾结石。然而,当环境炎热时,无论饮水量是否充足,特定亚组患者患肾结石的风险更高。